Chris Hassig

Chris Hassig, Ph.D.

Chief Scientific Officer

Prior to joining Boundless Bio, Dr. Hassig served as Chief Scientific Officer of Sierra Oncology, a publicly traded clinical development stage company focused in hematology and oncology. He previously served in a series of roles of increasing responsibility at the Sanford Burnham Prebys Medical Discovery Institute, culminating as Vice President of Drug Discovery. Dr. Hassig also held several positions within the Biology and Lead Discovery departments at Kalypsys, Inc., a private biopharmaceutical company specializing in small molecule drug discovery and development. He began his career at the Scripps Research Institute, where he still holds an academic appointment. Dr. Hassig earned a B.A. in Chemistry and Biochemistry from the University of California, San Diego, and a Ph.D. in Molecular and Cellular Biology from Harvard University. He completed a Postdoctoral Fellowship at the University of California, Berkeley.

"At Boundless Bio, we are pioneering an innovative approach to tackling cancers that leverages our discoveries in tumor ecDNA biology."